The Critical Care Community is currently at its most organized, and motivated, and on a mission to improve outcomes in sepsis. This is driving a rigorous assessment of care strategies which is gathering speed and showing results. This will yield many opportunities for developing products, but current interventions' roles will change, with impacts on how they are measured, used and valued.

Scope

Insight into clinical and commercial developments tackling predisposition, infection, response and organ dysfunction A translation of the complex, multifaceted processes involved in sepsis into commercial realities for industry Perspectives from Contract Research, Biotech, Pharmaceutical and Diagnostics sectors and leading figures from the sepsis and critical care community Assessment of the impact of the Surviving Sepsis Campaign and the changes in its latest set of guidelines on prescribing physicians

Highlights

The critical care community's rigorous assessment of current management strategies is now gathering speed and showing results, gaining more converts and highlighting new perspectives on sepsis-related processes Current interventions used in sepsis are typically either repurposed from other disease areas, or based on nascent understandings of the processes in play Whilst this improved understanding may yield many new opportunities for developing new interventions, the understanding of the roles of current interventions may be turned upside-down, with implications for how they are measured, used, and indeed, valued in improving outcomes

Reasons to Purchase

Understand the clinical and commercial characteristics and priorities for an increasingly complex therapy area Identify the elements of strategies that will either kept players at the top of their field or fail completely Understand how these businesses and strategies relate to your interest in the market, and how to position your products and services accordingly.